ID   MCC-60
AC   CVCL_LM85
AS   CVCL_A1QM
SY   P3-CL; CL3
DR   cancercelllines; CVCL_LM85
DR   DSMZ; ACC-815
DR   DSMZCellDive; ACC-815
DR   GEO; GSM4563057
DR   Wikidata; Q54904248
RX   PubMed=33087752;
CC   Population: Caucasian.
CC   Doubling time: 42 hours (PubMed=33087752); ~70-80 hours (DSMZ=ACC-815).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465His (c.1394G>A); ClinVar=VCV000376415; Zygosity=Heterozygous (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Heterozygous (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Heterozygous (PubMed=33087752).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.902delC); ClinVar=VCV000233908; Zygosity=Heterozygous (PubMed=33087752).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): DSMZ=ACC-815; PubMed=33087752
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12 (DSMZ=ACC-815)
ST   CSF1PO: 11,12 (PubMed=33087752)
ST   D13S317: 10 (DSMZ=ACC-815)
ST   D13S317: 13 (PubMed=33087752)
ST   D16S539: 8,14
ST   D18S51: 17,19
ST   D19S433: 13,14
ST   D21S11: 33,34
ST   D2S1338: 17,24
ST   D3S1358: 13,18,19
ST   D5S818: 11,13
ST   D7S820: 9.3,10.3,13 (PubMed=33087752)
ST   D7S820: 12 (DSMZ=ACC-815)
ST   D8S1179: 11,13
ST   FGA: 19,20,22.2
ST   Penta D: 12,14
ST   Penta E: 16
ST   TH01: 7,8,9 (PubMed=33087752)
ST   TH01: 7,9 (DSMZ=ACC-815)
ST   TPOX: 8 (DSMZ=ACC-815)
ST   TPOX: 8,11 (PubMed=33087752)
ST   vWA: 13,18 (PubMed=33087752)
ST   vWA: 14,18 (DSMZ=ACC-815)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
RX   PubMed=33087752; DOI=10.1038/s41598-020-74797-0; PMCID=PMC7578805;
RA   Hirsch D., Seyfried S., Staib T., Fiedler D., Sauer C., Ried T.,
RA   Witt S., Rueckert F., Gaiser T.;
RT   "Newly established gastrointestinal cancer cell lines retain the
RT   genomic and immunophenotypic landscape of their parental cancers.";
RL   Sci. Rep. 10:17895.1-17895.11(2020).
//